Noble Medical Technologies, Inc.

CIK:0001433593|SEC Filings

STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
STATEMENTS OF OPERATIONS (USD $)	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
NET REVENUES
OPERATING EXPENSES:
Consulting fees	57,820		176,450
Management service - stockholder	203,333		609,999
Professional fees	64,535	7,500	158,212	22,286
Officer's compensation	1,042		3,126
General and administrative expenses	15,346		72,895
Total operating expenses	342,076	7,500	1,020,682	22,286
LOSS FROM OPERATIONS	(342,076)	(7,500)	(1,020,682)	(22,286)
OTHER (INCOME) EXPENSE:
Provision for loan loss			250,000
Interest income	(227)		(1,035)
Other (income) expense, net	118,838		587,409
LOSS BEFORE INCOME TAXES	(460,914)	(7,500)	(1,608,091)	(22,286)
INCOME TAX PROVISION
NET LOSS	(460,914)	(7,500)	(1,608,091)	(22,286)
NET LOSS PER COMMON SHARE: - BASIC AND DILUTED	$ (0.11)	$ 0.00	$ (0.38)	$ (0.01)
Weighted average common shares outstanding - basic and diluted	4,188,000	4,188,000	4,188,000	4,188,000
All Other
OTHER (INCOME) EXPENSE:
Amortization of notes payable discount	90,940		254,069
Related Party
OTHER (INCOME) EXPENSE:
Amortization of notes payable discount	$ 28,125		$ 84,375

STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
STATEMENTS OF CASH FLOWS (USD $)	Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,608,091)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	1,719
Provision for loan loss	250,000
Equity instruments based compensation	93,126
Changes in operating assets and liabilities:
Travel advances	(3,500)
Accounts payable	60,015
Accrued stockholder services	249,999
NET CASH USED IN OPERATING ACTIVITIES	(683,927)
CASH FLOWS FROM FINANCING ACTIVITIES:
Loan receivable - related party	(250,000)
Proceeds from notes payable	670,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	420,000
NET CHANGE IN CASH	(263,927)
Cash at beginning of period	527,993
Cash at end of period	264,066
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid
Income taxes paid
All Other
Changes in operating assets and liabilities:
Accrued expenses	(11,893)
Amortization of discount on notes payable	254,069
Related Party
Changes in operating assets and liabilities:
Accrued expenses	(53,746)
Amortization of discount on notes payable	$ 84,375

BALANCE SHEETS (USD $)	Sep. 30, 2011	Dec. 31, 2010
CURRENT ASSETS:
Cash	$ 264,066	$ 527,993
Travel advances	3,500
Total Current Assets	267,566	527,993
OFFICE EQUIPMENT:
Office equipment	11,458	11,458
Accumulated depreciation	(2,278)	(559)
Office Equipment, net	9,180	10,899
Total Assets	276,746	538,892
CURRENT LIABILITIES:
Accounts payable	60,015
Notes payable, net of discount	860,319	187,500
Note payable - director, net of discount	271,875	187,500
Total Current Liabilities	1,220,291	468,721
LONG-TERM SERVICE ARRANGEMENT - STOCKHOLDER	249,999
Total Liabilities	1,470,290	468,721
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock at $0.0001 par value: 1,000,000 shares authorized, none issued or outstanding
Common stock at $0.0001 par value: 20,000,000 shares authorized, 4,188,000 shares issued and outstanding	419	419
Additional paid-in capital	663,466	319,090
Accumulated deficit	(1,857,429)	(249,338)
Total Stockholders' Equity (Deficit)	(1,193,544)	70,171
Total Liabilities and Stockholders' Equity (Deficit)	276,746	538,892
All Other
CURRENT LIABILITIES:
Accrued expenses	16,821	28,714
Related Party
CURRENT LIABILITIES:
Accrued expenses	$ 11,261	$ 65,007